Serotonin receptor modulators in the treatment of irritable bowel syndrome

Overview of attention for article published in Therapeutics and Clinical Risk Management, February 2008

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (94th percentile)
High Attention Score compared to outputs of the same age and source (80th percentile)

So far, Altmetric has seen 2 news stories from 2 outlets.

Zelnorm (tegaserod), an oral short-term treatment of irritable bowel syndrome and constipation (IBS-C), is being removed from…

Zelnorm (tegaserod), an oral short-term treatment of irritable bowel syndrome and constipation (IBS-C), is being removed from…